The Trans Fat Ban that Never Was

The Trans Fat Ban that Never Was

The FDA seems to be waiting for GMO soybeans to be ready before it follows through on its promise to ban the toxic fats. A new study published in the journal Preventing Chronic Disease, available on the CDC’s website, shows that Americans are consuming much more trans fat than they realize. A federal loophole allows food companies […]

Read More
Problems with Compounding Regulation?

Problems with Compounding Regulation?

Recent regulations released by the FDA contain several provisions that are harmful to doctors, patients, and compounding pharmacists. Office Use: This is an area of the rulemaking that has garnered the biggest reaction from the compounding community. Congress and the FDA have required a patient-specific prescription for all drugs compounded, with a narrow exception if […]

Read More
How is Compounding Regulated?

How is Compounding Regulated?

Compounding has recently undergone a regulatory overhaul by Congress and the FDA. In November 2013, the Drug Quality and Security Act (DQSA) was signed in to law, amending the federal Food, Drug, and Cosmetic Act (FDCA) and overhauling the regulation of compounding. In July 2014, the FDA released rules and guidances and other documents implementing […]

Read More
Dr. Einsteinburger’s PSA

Dr. Einsteinburger’s PSA

Dr. Einsteinburger, scientific director of Biosantech (no relation to any real biotech companies located in the St. Louis area), elaborates on the latest innovations by the leader in biotech.

Read More